Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NKTR compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
NKTR
Nektar Therapeutics
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
NKTR
Nektar Therapeutics
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NKTR
12
—
UCB
unlisted
customer
—
Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)
unlisted
customer
AZN
AstraZeneca
customer
PFE
Pfizer
customer
8 more · NKTR chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
NKTR
Nektar Therapeutics
Change
36.35
· pre 37.02
· delayed
Mkt cap
$1.2B
Revenue
$10M
Q2 FY26
Revenue
$55M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,346.78
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
NKTR
Nektar Therapeutics
vs
LLY
ELI Lilly & Co
36.35
pre 37.02
delayed
Price
1,371.32
pre 1,346.78
delayed
$1.2B
Mkt cap
$1.2T
Q2 FY26
$10M
Revenue
$24.4B
Q3 FY26
FY25
$55M
Revenue
$65.2B
FY25
Change
Change
NKTR
36.35
vs
LLY
1,371.32
Pre-market
Nov 6 '26
delayed